Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Haemofact No 6 reported that Lord Glenarthur, Parliamentary Under-Secretary of State for Health, speaking in the House of Lords, had made it clear that all home produced Factor 8 would be heat treated from April 1985.

  • Read more about Haemofact No 6 reported that Lord Glenarthur, Parliamentary Under-Secretary of State for Health, speaking in the House of Lords, had made it clear that all home produced Factor 8 would be heat treated from April 1985.

At a UKHCDO Hepatitis Working Party meeting Dr Craske identified eight patients treated with (unheated) Factor 9 who had seroconverted.

  • Read more about At a UKHCDO Hepatitis Working Party meeting Dr Craske identified eight patients treated with (unheated) Factor 9 who had seroconverted.

During a meeting of the AIDS group of haemophilia centre directors, directors were recommended to use only heat-treated products now these were available.

  • Read more about During a meeting of the AIDS group of haemophilia centre directors, directors were recommended to use only heat-treated products now these were available.

In the minutes of an AIDS group of haemophilia centre directors' meeting, Dr Mortimer told the meeting that he was concerned to see that a large number of centres were still using non-heat-treated Factor 8, and suggested that all directors should be advised not to use it.

  • Read more about In the minutes of an AIDS group of haemophilia centre directors' meeting, Dr Mortimer told the meeting that he was concerned to see that a large number of centres were still using non-heat-treated Factor 8, and suggested that all directors should be advised not to use it.

In a letter from Dr Biggs to Dr Godber, she called attention to the lack of organisation, apparatus and buildings needed in order to produce Factor 8.

  • Read more about In a letter from Dr Biggs to Dr Godber, she called attention to the lack of organisation, apparatus and buildings needed in order to produce Factor 8.

An editorial in the "British Medical Journal" asserted that the protein fractionation centres lacked sufficient staff, accommodation, equipment and the basic organisational units to do the job.

  • Read more about An editorial in the "British Medical Journal" asserted that the protein fractionation centres lacked sufficient staff, accommodation, equipment and the basic organisational units to do the job.

In a memo from Dr Isaacs to Dr Rotblat, Dr Isaacs attached a letter received from Peter Jones in which he suggested taking action against the Armour material.

  • Read more about In a memo from Dr Isaacs to Dr Rotblat, Dr Isaacs attached a letter received from Peter Jones in which he suggested taking action against the Armour material.

Dr Hill, of Birmingham Children's Hospital, wrote to the Department of Health stating his belief that there had been three definite cases and one probable case of seroconversion amongst his patients.

  • Read more about Dr Hill, of Birmingham Children's Hospital, wrote to the Department of Health stating his belief that there had been three definite cases and one probable case of seroconversion amongst his patients.

In a minute from D O Hagger to Mr O'Connor, it was decided that, in light of recent seroconversion cases, if Armour did not agree to a voluntary withdrawal the DHSS would need to consider the case further as to what their course of action should be.

  • Read more about In a minute from D O Hagger to Mr O'Connor, it was decided that, in light of recent seroconversion cases, if Armour did not agree to a voluntary withdrawal the DHSS would need to consider the case further as to what their course of action should be.

In a memo from Dr Walford to Dr Fowler, Dr Walford flagged that Travenol (Hyland) were planning a symposium in early 1983 to launch a reduced hepatitis risk product.

  • Read more about In a memo from Dr Walford to Dr Fowler, Dr Walford flagged that Travenol (Hyland) were planning a symposium in early 1983 to launch a reduced hepatitis risk product.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 215
  • Page 216
  • Page 217
  • Page 218
  • Current page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.